Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fortress Biotech Inc Series A P

6.45
+0.22993.70%
Post-market: 6.450.0001+0.00%17:09 EDT
Volume:18.46K
Turnover:116.59K
Market Cap:325.48M
PE:-2.40
High:6.51
Open:6.28
Low:6.00
Close:6.22
Loading ...
May 26, 2020

Correspondence

CORRESP [Cover] - Correspondence
May 19, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 11, 2020

Major Issues Report

Current report, items 2.02 and 9.01
May 11, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 28, 2020

Correspondence

CORRESP [Cover] - Correspondence
Mar 23, 2020

Major Issues Report

8-K - Current report
Mar 16, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 16, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Feb 12, 2020

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Jan 27, 2020

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 31, 2019

Major Issues Report

Current report, item 5.02
Nov 26, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Nov 26, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 22, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Nov 12, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 12, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]